Putative risk alleles for LATE-NC with hippocampal sclerosis in population-representative autopsy cohorts.


Journal

Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781

Informations de publication

Date de publication:
03 2020
Historique:
received: 01 05 2019
accepted: 18 07 2019
pubmed: 4 8 2019
medline: 14 1 2021
entrez: 4 8 2019
Statut: ppublish

Résumé

Limbic-predominant age-related TAR-DNA-binding protein-43 (TDP-43) encephalopathy with hippocampal sclerosis pathology (LATE-NC + HS) is a neurodegenerative disorder characterized by severe hippocampal CA1 neuron loss and TDP-43-pathology, leading to cognitive dysfunction and dementia. Polymorphisms in GRN, TMEM106B and ABCC9 are proposed as LATE-NC + HS risk factors in brain bank collections. To replicate these results in independent population-representative cohorts, hippocampal sections from brains donated to three such studies (Cambridge City over 75-Cohort [CC75C], Cognitive Function and Ageing Study [CFAS], and Vantaa 85+ Study) were stained with hematoxylin-eosin (n = 744) and anti-pTDP-43 (n = 713), and evaluated for LATE-NC + HS and TDP-43 pathology. Single nucleotide polymorphism genotypes in GRN rs5848, TMEM106B rs1990622 and ABCC9 rs704178 were determined. LATE-NC + HS (n = 58) was significantly associated with the GRN rs5848 genotype (χ

Identifiants

pubmed: 31376286
doi: 10.1111/bpa.12773
pmc: PMC7065086
doi:

Substances chimiques

GRN protein, human 0
Membrane Proteins 0
Nerve Tissue Proteins 0
Progranulins 0
TMEM106B protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-372

Subventions

Organisme : Medical Research Council
ID : G1000691
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105292687
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0900652
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0502157
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400074
Pays : United Kingdom
Organisme : UK Medical Research Council
ID : MRC.U.1052.00.013
Pays : International
Organisme : Medical Research Council
ID : G9901400
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022656/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1100540
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Références

Acta Neuropathol. 2016 Apr;131(4):571-85
pubmed: 26810071
J Neurochem. 2015 Sep;134(6):1026-39
pubmed: 26115089
Neuroepidemiology. 2006;26(2):76-82
pubmed: 16352910
Neurobiol Aging. 2017 May;53:193.e17-193.e25
pubmed: 28131462
Int J Epidemiol. 2006 Oct;35(5):1140-5
pubmed: 16980700
Neurodegener Dis. 2010;7(1-3):170-4
pubmed: 20197700
Hum Mol Genet. 2008 Dec 1;17(23):3631-42
pubmed: 18723524
Acta Neuropathol. 2014 Sep;128(3):411-21
pubmed: 24899141
Brain Pathol. 2018 Jul;28(4):548-559
pubmed: 28833898
J Neuropathol Exp Neurol. 2015 Jan;74(1):75-84
pubmed: 25470345
Neurol Genet. 2018 Jan 18;4(1):e211
pubmed: 29379882
Acta Neuropathol. 2014;127(6):825-43
pubmed: 24770881
Curr Neuropharmacol. 2011 Dec;9(4):632-42
pubmed: 22654721
J Alzheimers Dis. 2014;42(2):641-50
pubmed: 25170584
Brain. 2019 Jun 1;142(6):1503-1527
pubmed: 31039256
Neurology. 2011 Feb 1;76(5):467-74
pubmed: 21178100
J Neurosci. 2007 Sep 26;27(39):10530-4
pubmed: 17898224
J Alzheimers Dis. 2018;63(1):263-272
pubmed: 29614661
Neurology. 2012 Aug 14;79(7):717-8
pubmed: 22855871
Int J Epidemiol. 2007 Feb;36(1):40-6
pubmed: 17510074
Brain. 2011 May;134(Pt 5):1506-18
pubmed: 21596774
PLoS Genet. 2014 Sep 04;10(9):e1004606
pubmed: 25188341

Auteurs

Suvi R K Hokkanen (SRK)

Institute of Public Health, University of Cambridge, Cambridge, UK.

Mia Kero (M)

Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.

Karri Kaivola (K)

Molecular Neurology, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Department of Neurology, Helsinki University Hospital, Helsinki, Finland.

Sally Hunter (S)

Institute of Public Health, University of Cambridge, Cambridge, UK.

Hannah A D Keage (HAD)

Cognitive Ageing and Impairment Neurosciences Laboratory, School of Psychology, Social Work and Social Policy, University of South Australia, Adelaide, Australia.

Anna Kiviharju (A)

Molecular Neurology, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Department of Neurology, Helsinki University Hospital, Helsinki, Finland.

Anna Raunio (A)

Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.

Pentti J Tienari (PJ)

Molecular Neurology, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Department of Neurology, Helsinki University Hospital, Helsinki, Finland.

Anders Paetau (A)

Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.

Fiona E Matthews (FE)

Institute for Health and Society, Newcastle University, Newcastle upon Tyne, UK.

Jane Fleming (J)

Institute of Public Health, University of Cambridge, Cambridge, UK.

Caroline Graff (C)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, J10:20, Visionsgatan 4, Solna, 171 64, Sweden.
Theme Aging, Genetics Unit, Karolinska University Hospital-Solna, QA22, Stockholm, Sweden.

Tuomo M Polvikoski (TM)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.

Liisa Myllykangas (L)

Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.

Carol Brayne (C)

Institute of Public Health, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH